Therapy and clinical trials: ezetimibe.

作者信息

Jialal Ishwarlal, Kappagoda Tissa

出版信息

Curr Opin Lipidol. 2003 Dec;14(6):643-6. doi: 10.1097/00041433-200312000-00015.

DOI:10.1097/00041433-200312000-00015

PMID:14624143

Abstract

摘要

相似文献

[1]

Therapy and clinical trials: ezetimibe.

Curr Opin Lipidol. 2003-12

[2]

[Ezetimibe--intestinal cholesterol absorbtion inhibitor].

Kardiol Pol. 2006-12

[3]

Zetia (ezetimibe).

Congest Heart Fail. 2003

[4]

Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.

Circulation. 2003-7-1

[5]

Atherosclerosis: cell biology and lipoproteins: cholesterol absorption inhibitors: gateway therapy for hypercholesterolaemia.

Curr Opin Lipidol. 2002-12

[6]

Ezetimibe (Schering-Plough).

Curr Opin Investig Drugs. 2001-3

[7]

Ezetimibe: cholesterol lowering and beyond.

Expert Rev Cardiovasc Ther. 2008-4

[8]

Combination therapy in cholesterol reduction: focus on ezetimibe and statins.

Vasc Health Risk Manag. 2008

[9]

Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study).

J Atheroscler Thromb. 2012-2-15

[10]

Lipid-lowering study raises issues of therapy's value.

Am J Health Syst Pharm. 2008-4-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Therapy and clinical trials: ezetimibe.

作者信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献